Fox Chase Cancer Center goes beyond offering innovative treatments for lung cancer. We also offer clinical trials that can lead to better treatment for our patients, while paving the way for future lung cancer treatments.
Today’s innovative treatments for lung cancer, such as immunotherapy and photodynamic therapy, all started out in clinical trials. Many patients benefited from these trials, and all who joined them contributed to helping researchers develop a much stronger understanding of treatments for lung cancer.
If you’re interested in clinical trials, here is some information you need to know.
About Joining a Clinical Trial for Lung Cancer
A treatment clinical trial is a research study meant to improve current treatments or test new treatments for patients with cancer. When clinical trials show that a new treatment is better than an older one, it may become the new standard treatment.
Fox Chase Cancer Center physicians are also world-renowned cancer researchers. The results of studies conducted by Fox Chase physicians have been key to advancing our understanding of lung cancer diagnosis and treatment around the world.
Our physicians and researchers are actively developing and evaluating a number of new therapies, often before they are available anywhere else. We encourage eligible patients to participate in clinical trials that are appropriate for their stage and type of lung cancer.
See our list of current lung cancer clinical trials below.
If you’re interested in learning more about clinical trials at Fox Chase, talk to your physician or call 215-214-1515. We’ll be happy to answer any questions you have.
“Fox Chase Cancer Center has really been a major figure in the development of immunotherapy. One of our early trials led to approval of one of the immunotherapy drugs. Today, we have multiple researchers asking us to run their trials for new immunotherapy drugs. There’s a real depth of leadership and experience in this area, and a commitment to further studies.” — Joseph Treat, MD, lung cancer specialist
For more information about clinical trial studies or to inquire about eligibility, please call the Office of Clinical Research at 215-214-1515 or use the online form.
Please note there are limited slots for studies, especially Phase I trials, which study a drug’s safety and side effects. Participants should call to confirm availability.